Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer

I-kappa-B kinase e (IKBKE; IKKε) has been recently identified as a breast cancer oncogene, and its alteration appears to be an early event in breast cancer development. In this study, we demonstrated that IKKε is frequently overexpressed and activated in human ovarian cancer cell lines and primary t...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Guo, Jian-Ping, Shu, Shao-Kun, He, Lili, Lee, Yi-Chun, Kruk, Patricia A., Grenman, Seija, Nicosia, Santo V., Mor, Gil, Schell, Michael J., Coppola, Domenico, Cheng, Jin Q.
Format: Artigo
Język:Inglês
Wydane: American Society for Investigative Pathology 2009
Hasła przedmiotowe:
Regular Articles
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2708818/
https://ncbi.nlm.nih.gov/pubmed/19497997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.080767
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy